Woodford Investment Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Woodford Investment Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,948,325	Closed	-$105M	–	8
2017 Q4	$105M	Sell	1,948,325 -12,000	-0.6%	-$657K	7.08%	6
2017 Q3	$112M	Sell	1,960,325 -17,439	-0.9%	-$1.02M	5.14%	7
2017 Q2	$119M	Buy	1,977,764 +1,186,500	+150%	+$67.6M	4.37%	6
2017 Q1	$43.1M	Buy	+791,264	New	+$39M	1.78%	7

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Woodford Investment Management's BIVV Position: Q1 2018 in Review

Woodford Investment Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 1,948,325 shares — an estimated $105M sold.

Woodford Investment Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $119M in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Woodford Investment Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Woodford Investment Management sold 1,948,325 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $105M.
Woodford Investment Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Woodford Investment Management's Bioverativ Inc. Common Stock position peaked at $119M in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Woodford Investment Management's 13F filing for Q1 2018, filed 11 May 2018.